The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease.

Dat T TranDan PalfreyRobert Welsh

Published in: PharmacoEconomics - open (2021)

The healthcare costs for HRCVD patients were substantial but decreased over time. The costs were highest in the year following the index event and decreased thereafter. Secondary prevention patients incurred higher costs than the primary prevention patients.

Keyphrases

healthcare
end stage renal disease
cardiovascular disease
ejection fraction
newly diagnosed
peritoneal dialysis
metabolic syndrome
risk factors
cardiovascular events
affordable care act